BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24804778)

  • 21. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.
    Chinnam M; Xu C; Lama R; Zhang X; Cedeno CD; Wang Y; Stablewski AB; Goodrich DW; Wang X
    PLoS Genet; 2022 May; 18(5):e1010171. PubMed ID: 35588102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination.
    Wang X; Wang J; Jiang X
    J Biol Chem; 2011 Jul; 286(27):23725-34. PubMed ID: 21572037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mdm2 and MdmX partner to regulate p53.
    Wang X; Jiang X
    FEBS Lett; 2012 May; 586(10):1390-6. PubMed ID: 22673503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of polyubiquitination by human anaphase-promoting complex: RING repurposing for ubiquitin chain assembly.
    Brown NG; Watson ER; Weissmann F; Jarvis MA; VanderLinden R; Grace CRR; Frye JJ; Qiao R; Dube P; Petzold G; Cho SE; Alsharif O; Bao J; Davidson IF; Zheng JJ; Nourse A; Kurinov I; Peters JM; Stark H; Schulman BA
    Mol Cell; 2014 Oct; 56(2):246-260. PubMed ID: 25306923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
    Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
    Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC2
    Chen A; Bai L; Zhong K; Shu X; Wang A; Xiao Y; Zhang K; Shen C
    FASEB J; 2020 Sep; 34(9):12009-12023. PubMed ID: 32687671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoactivation of the MDM2 E3 ligase by intramolecular interaction.
    Cheng Q; Song T; Chen L; Chen J
    Mol Cell Biol; 2014 Aug; 34(15):2800-10. PubMed ID: 24842904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unlocking the Mdm2-p53 loop: ubiquitin is the key.
    Clegg HV; Itahana K; Zhang Y
    Cell Cycle; 2008 Feb; 7(3):287-92. PubMed ID: 18235222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budding yeast RSI1/APC2, a novel gene necessary for initiation of anaphase, encodes an APC subunit.
    Kramer KM; Fesquet D; Johnson AL; Johnston LH
    EMBO J; 1998 Jan; 17(2):498-506. PubMed ID: 9430641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MAD2B-APC/C-MDM2 axis mediates acute kidney injury by modulating p53.
    Hao Z; Yuan Q; Tang H; Lei C; Chen Y; Su H; Zhang C
    FEBS J; 2023 Aug; 290(15):3858-3876. PubMed ID: 37002708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
    Cheng Q; Chen L; Li Z; Lane WS; Chen J
    EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.
    Fan C; Wang X
    Cell Cycle; 2017 Apr; 16(7):660-664. PubMed ID: 28166445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
    Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
    Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.